ECM
ABBV icon

ExodusPoint Capital Management’s AbbVie ABBV Stock Holding History

ExodusPoint Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-51,628
Closed -$10.8M – 1411
2025
Q1 		$10.8M Buy
51,628
+32,357
+168% +$6.29M 0.11% 185
2024
Q4 		$3.42M Sell
19,271
-18,201
-49% -$3.35M 0.02% 551
2024
Q3 		$7.4M Buy
+37,472
New +$6.99M 0.05% 296
2024
Q1 		– Sell
-23,088
Closed -$3.98M – 1448
2023
Q4 		$3.58M Sell
23,088
-207,105
-90% -$30.2M 0.02% 424
2023
Q3 		$34.3M Sell
230,193
-92,885
-29% -$13.6M 0.33% 51
2023
Q2 		$43.5M Buy
323,078
+202,892
+169% +$29.8M 0.35% 41
2023
Q1 		$19.2M Buy
120,186
+118,218
+6,007% +$18.1M 0.16% 117
2022
Q4 		$318K Buy
+1,968
New +$302K ﹤0.01% 1332
2022
Q3 		– Sell
-42,941
Closed -$6.58M – 1826
2022
Q2 		$6.58M Buy
42,941
+20,795
+94% +$3.18M 0.08% 313
2022
Q1 		$3.59M Buy
+22,146
New +$3.22M 0.05% 509
2021
Q4 		– Sell
-77,978
Closed -$8.41M – 2113
2021
Q3 		$8.41M Buy
77,978
+45,610
+141% +$5.21M 0.11% 233
2021
Q2 		$3.65M Sell
32,368
-62,225
-66% -$7.01M 0.04% 466
2021
Q1 		$10.2M Buy
94,593
+13,865
+17% +$1.48M 0.15% 124
2020
Q4 		$8.65M Buy
80,728
+59,192
+275% +$5.69M 0.08% 148
2020
Q3 		$1.89M Sell
21,536
-7,192
-25% -$677K 0.04% 426
2020
Q2 		$2.82M Buy
+28,728
New +$2.53M 0.07% 308
2020
Q1 		– Sell
-26,984
Closed -$2.39M – 1032
2019
Q4 		$2.39M Sell
26,984
-9,936
-27% -$825K 0.04% 299
2019
Q3 		$2.8M Buy
36,920
+26,008
+238% +$1.78M 0.1% 179
2019
Q2 		$794K Buy
+10,912
New +$858K 0.03% 322

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

ExodusPoint Capital Management's ABBV Position: Q2 2025 in Review

ExodusPoint Capital Management sold out of AbbVie (ABBV) in Q2 2025, closing a stake of 51,628 shares — an estimated $10.8M sold.

ExodusPoint Capital Management first reported a position in ABBV in Q2 2019 and held it in 19 quarters. The position peaked at $43.5M in Q2 2023. 3,780 funds tracked by Wall St. Rank hold ABBV as of Q2 2025.

  • ExodusPoint Capital Management reported no remaining AbbVie position as of Q2 2025 after selling out during the quarter.
  • ExodusPoint Capital Management sold 51,628 AbbVie shares in Q2 2025, an estimated $10.8M.
  • ExodusPoint Capital Management first reported a position in AbbVie in Q2 2019 and held it in 19 quarters.
  • ExodusPoint Capital Management's AbbVie position peaked at $43.5M in Q2 2023.
  • 3,780 funds tracked by Wall St. Rank held AbbVie as of Q2 2025.

Based on ExodusPoint Capital Management's 13F filing for Q2 2025, filed 13 Aug 2025.